Search for: "In Re Opioid Litig." Results 61 - 80 of 135
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
18 Mar 2021, 8:11 am by Dan Bressler
‘This is a business decision, like Jones Day representing Trump and McKinsey on the opioids thing,” he wrote. [read post]
25 Jan 2021, 9:39 am by Seeger Weiss LLP
Martinotti in the In re Elmiron (Pentosan Polysulfate Sodium) Products Liability Litigation. [read post]
15 Nov 2020, 6:57 pm by Omar Ha-Redeye
While there continue to be suspected opioid deaths in shelters, there have also been suspected opioid deaths in park encampments. [read post]
9 Nov 2020, 12:18 pm by fjhinojosa
Robert Sherwin’s article Shoot First, Litigate Later: Declaratory Judgment Actions, Procedural Fencing, and Itchy Trigger Fingers is cited in the following article: Daniel Fisher, Walmart hopes old law will block feds’ suit over opioid ‘unwritten expectations’, Southeast Texas Record (2020). 16. [read post]
6 Nov 2020, 3:00 am by Jim Sedor
The campaign’s aggressive legal posture while the presidential race remains unresolved underscored how the close margins in key states have raised the stakes for litigation over which ballots will count. [read post]
23 Oct 2020, 5:03 am by Seeger Weiss LLP
“Cases like In re National Prescription Opiate Litigation seek to recover funds for state and local governments addressing the harm to their communities caused by defendants’ conduct. [read post]
15 Oct 2020, 6:32 am by Adam Steinman
Yesterday, Judge Polster partially granted the plaintiffs’ motion for sanctions against the Allergan and Teva defendants in the In re: National Prescription Opiate Litigation MDL. [read post]
8 Oct 2020, 7:03 pm by Seeger Weiss LLP
” The post Seeger Weiss urges a full-court review of proposed negotiation class in opioid litigation appeared first on Seeger Weiss LLP. [read post]
5 Oct 2020, 9:09 am by Patrick T. Ryan
  In re: Nat’l Prescription Opiate Litig., ___ F.3d ___, 2020 WL 5701916 (6th Cir. [read post]
25 Sep 2020, 9:03 am by Adam Steinman
Yesterday, the Sixth Circuit issued a 2-1 decision in In re National Prescription Opiate Litigation, a much-anticipated case about the certification of a negotiation class in the Opioid MDL. [read post]
17 Sep 2020, 5:57 pm by Anna Salvatore
And the question of whether or not you're going to impute that to the corporation and take down the corporation as well as largely a discretionary call by prosecutors. [read post]
28 Jul 2020, 4:00 am by Adam Steinman
The Sixth Circuit will hear oral argument this morning (9:00 am EDT) in the Opioid MDL (In re: Nat’l Prescription Opiate Litigation, No. 19-4097 & 19-4099). [read post]
16 Apr 2020, 6:14 am by Adam Steinman
Yesterday a Sixth Circuit panel issued its decision in In re National Prescription Opiate Litigation, granting the pharmacy defendants’ petition for a writ of mandamus regarding the district court’s order allowing the counties to amend their complaints to add new... [read post]
29 Feb 2020, 6:42 pm by Bill Marler
Marler Clark is the only law firm in the nation with a practice focused exclusively on foodborne illness litigation. [read post]
District Court for the Northern District of Ohio, styled In Re: National Prescription Opiate Litigation (MDL No. 2804) (the “MDL”). [read post]
9 Jan 2020, 9:05 pm by Alana Bevan
” WHAT WE’RE READING THIS WEEK How did the use of opioids—a legal, highly regulated drug—develop into a national public health crisis? [read post]